Medical devices, healthcare technology and the business of care
510(k) clearance · K262816

EXG PulseLinQ Cables (EXGPL)

Cb Innovations, LLC · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK262816

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 10/30/2026 for EXG PulseLinQ Cables (EXGPL), submitted by Cb Innovations, LLC of Carlsbad, California, under 510(k) number K262816. The application was received 08/07/2026 as a Traditional 510(k) and was not reviewed by a third party. The device falls under product code DSA, regulation 870.2900, for cable, transducer and electrode, patient (including connector), with a Cardiovascular regulation medical specialty and Cardiovascular review panel.

SESE in this 510(k) context means the submitted device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record lists no combination product and no authorized predetermined change control plan. The available source does not identify the predicate device, describe the specific components or changes submitted, or give indications for use; those details would sit in the linked summary document, which was not reviewed here.

No clinical, efficacy or patient-selection conclusions are drawn from this clearance record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262816
Regulatory pathway
510(k) premarket notification
Product code
DSA
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cable, Transducer And Electrode, Patient, (Including Connector).

Product code
DSA
FDA device class
2

FDA decision timeline

  1. K262816 received

    Application receipt date recorded by FDA.

  2. K262816 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cb Innovations, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Carlsbad, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records